Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-013895
Filing Date
2020-11-16
Accepted
2020-11-16 16:43:18
Documents
67
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20200930x10q.htm   iXBRL 10-Q 1180301
2 EX-10.17 tmb-20200930xex10d17.htm EX-10.17 25409
3 EX-31.1 tmb-20200930xex31d1.htm EX-31.1 13349
4 EX-31.2 tmb-20200930xex31d2.htm EX-31.2 13275
5 EX-32.1 tmb-20200930xex32d1.htm EX-32.1 7206
6 EX-32.2 tmb-20200930xex32d2.htm EX-32.2 7223
  Complete submission text file 0001558370-20-013895.txt   5119134

Data Files

Seq Description Document Type Size
7 EX-101.SCH tmb-20200930.xsd EX-101.SCH 42457
8 EX-101.CAL tmb-20200930_cal.xml EX-101.CAL 38177
9 EX-101.DEF tmb-20200930_def.xml EX-101.DEF 166204
10 EX-101.LAB tmb-20200930_lab.xml EX-101.LAB 419480
11 EX-101.PRE tmb-20200930_pre.xml EX-101.PRE 304938
12 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20200930x10q_htm.xml XML 674384
Mailing Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341
Business Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341 610-321-3700
Immunome Inc. (Filer) CIK: 0001472012 (see all company filings)

EIN.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39580 | Film No.: 201317786
SIC: 2834 Pharmaceutical Preparations